The Center for Neuro-Oncology offers state-of the-art treatment for patients with brain tumors, spinal cord tumors, and neurologic complications from cancer. Our specialists work to ensure you receive coordinated treatment and support. We focus on helping you cope with your illness and maintain the quality of your life.
The Center for Neuro-Oncology offers the latest advances in care for adult patients with tumors of the brain or spinal cord, as well as for neurologic complications of cancer and its treatments. Treatment for brain cancer is complex and treatment planning requires involvement from many subspecialists including neurosurgeons, radiation oncologists and medical oncologists. Through our Multidisciplinary Clinic, patients have the benefit of meeting with our team of surgical, medical, and radiation oncologists at one time and in one place to develop individualized treatment plans.
We focus on treating both common and rare brain tumors, including glioma, glioblastoma, oligodendroglioma, astrocytoma, meningioma, lymphoma, brain metasteses, and medulloblastoma.
Our clinicians are experts in treatment options that include precise neurosurgical techniques, radiation therapy that targets tumors while sparing surrounding tissues, and a variety of chemotherapy and molecular drugs targeting your type of cancer.
You may also benefit from our research program. As we search for new, more effective treatments, we are able to offer our patients access to a range of clinical trials for various types and stages of brain and spinal cord cancers.
Our approach to compassionate care centers on the individual needs of our patients and their families. Our team members work closely together to ensure that you receive carefully coordinated treatment and support. We focus on helping you cope with your illness and maintain the quality of your life.
You and your family are key members of the care team. While we understand your illness, you understand your own body. We welcome your questions and value your participation as we make decisions together.
View this Slideshare presentation by Patrick Wen, MD, director of Dana-Farber's Center for Neuro-Oncology, in which he discusses how molecular testing can help guide treatment decisions for patients with glioblastoma, meningioma, medulloblastoma, and other brain tumors. The presentation was originally given as a webinar hosted by the American Brain Tumor Association.
View this Slideshare presentation by Patrick Wen, MD, director of Dana-Farber's Center for Neuro-Oncology, in which he presents the latest treatment options and research for brain tumor patients.
View this Slideshare presentation by Dana-Farber nutritionist Emily Biever, MS, RD, LDN, in which she discusses healthy eating tips for brain tumor patients. Learn about diets, food fads, and healthy recipes.
View this Slideshare presentation by Dana-Farber neuropsychologist Clare Humphreys, PhD, in which she discusses the mental difficulties that brain tumor patients face, and how to cope with symptoms of treatment.
Treatment for brain cancers is complex, and treatment planning requires involvement and coordination among many subspecialists. That's why we take a multidisciplinary approach to developing a comprehensive treatment plan tailored to your type of cancer. Through our multidisciplinary clinic, you meet with a team of specialists, as a group, to develop an individualized treatment plan that works for your needs. The multidisciplinary team involved in coordination of your care includes specialists in:
We understand that cancer affects patients and their families in many ways. In addition to clinical care, we offer a wide range of support services to help you and your family manage your experience with cancer treatment and survivorship, including:
Depending on your diagnosis, your team may include the following specialists:
Rameen Beroukhim, MD, PhDEudocia Quant Lee, MD, MPHLakshmi Nayak, MDAndrew Norden, MD, MPHDavid A. Reardon, MDMikael Rinne MD, PhDPatrick Wen, MD
Lisa Doherty, APRN, OCNJulee Pulverenti, PA-CDebra Conrad LaFrankie, RN, OCNJennifer Rifenburg, NPSandra French Ruland, RN
Ayal Aizer, MD, MHSBrian Alexander, MD, MPHNils Arvold, MDKaren Marcus, MD
Shelly Lynn Beckley, NPSheila Connelly, RN Rachel Silverman, RN
Osama Al-Mefty, MDJohn Chi, MD, MPHEnnio A. Chiocca, MD, PhDElizabeth Claus, MD, PhDRose Du, MD, PhDIan Dunn, MDKai Frerichs, MDAlexandra Golby, MDWilliam B. Gormley, MDMichael W. Groff, MDMark Johnson, MD, PhDEdward Laws, MDTravis S. Tierney, MD, PhD
Sara June Dagen, RNSherry Iuliano, FNP-CMary Beth Mondello, NPSeth Santos, PADaniel Triggs, NP
Umberto De Girolami, MDMel Feany, MD, PhDRebecca Dunn Folkerth, MDHart Lidov, MDKeith Ligon, MD, PhDSandro Santagata, MD, PhD
Clare Humphreys, PhD
Rachel Allende,LICSW (Spanish and Portuguese-speaking patients)Sara E. Nemitz, LICSW (inpatient)Nancy Goldsmith Tharler, LICSW
Our basic science program explores why tumors develop in the brain (including the role of tumor stem cells), what drives tumor growth, and why some tumors are resistant to conventional treatments. This program brings together researchers with expertise in neuroscience, molecular genetics, cancer biology, and neurobiology.
Our research program is a leader in clinical trials for brain tumors. Our goal is to bring laboratory discoveries directly to patients, allowing us to offer new treatment options.
SearchClinical trials for patients with newly diagnosed brain tumors Clinical trials for recurrent glioblastomaClinical trials for non-glioblastoma brain tumors
Our researchers also work with the Adult Brain Tumor Consortium, the National Cancer Institute, the Ivy Foundation Early Phase Clinical Trials Consortium, and pharmaceutical companies to develop new approaches to the treatment of brain and spinal cord tumors.
The Brain Tumor Laboratories provide a unique environment for basic science researchers, medical students, research fellows, oncologists, pathologists, and neurosurgeons to take a multidisciplinary approach to understanding basic biology, and to develop new therapies to treat brain tumors. Current research focuses on the two most common types of tumors: gliomas and meningiomas.
Our team participates in the Surgical Planning Lab, which brings the power of computation and imaging to new areas of medicine. The lab collaborates with groups within Brigham and Women's Hospital, with researchers at Harvard Medical School, with local universities such as Harvard and MIT, and with gifted clinicians, researchers, and engineers throughout the world.
If you have never been seen before at Dana-Farber/Brigham and Women's Cancer Center, please call 877-442-3324 or use our online form to request an appointment.
You may schedule your first appointment for as soon as the next day. After scheduling, one of our nurses will call you to answer your questions and help you prepare for the appointment.
For all other inquiries, please call 617-632-2166.
Radiation Oncology: 617-732-6313, option 3Neurosurgery: 617-732-6810Referring physicians: 617-632-3703Fax: 617-632-4773
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: